SDZ
Sandoz Grp
Stock
Stock
ISIN: CH1243598427
Ticker: SDZ
CH1243598427
SDZ
Price
Price
CHART BY
Historical dividends and forecast
Sandoz Grp has so far distributed $0.495 in 2024. The next dividend will be paid on 07.05.2025
$0.499
CHART BY
Frequently asked questions
What is Sandoz Grp's market capitalization?
The market capitalization of Sandoz Grp is $16.30B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Sandoz Grp's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Sandoz Grp is 230.68. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What are the analyst ratings and target price for Sandoz Grp's stock?
Currently, 18 analysts cover Sandoz Grp's stock, with a consensus target price of $48.70. Analyst ratings provide insights into the stock's expected performance.
How many employees does Sandoz Grp have, and what sector and industry does it belong to?
Sandoz Grp employs approximately 20,000 people. It operates in the Health Care sector, specifically within the Pharmaceuticals: Major industry.
What is the free float of Sandoz Grp's shares?
The free float of Sandoz Grp is 408.16M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $16.30B
- Free Float
- 408.16M
- P/E ratio (TTM)
- 230.68
Pricing
- 1D span
- $40.97$41.90
- 52W span
- $27.86$47.08
Analyst Ratings
The price target is $48.70 and the stock is covered by 18 analysts.
Buy
12
Hold
6
Sell
0
Information
Sandoz Group AG engages in focusing on generic pharmaceuticals and bio similar medical products. It acquires, manages and sells investments and intellectual property in the healthcare and medical device industry and conducts all business at home and abroad. The firm can acquire, sell, debit and manage interests in other companies, intellectual property rights and real estate at home and abroad, as well as establish branches and subsidiaries at home and abroad. The company was founded on January 17, 2022 and is headquartered in Rotkreuz, Switzerland.
- Employees
- 20,000
- Industries
- Pharmaceuticals: Major
- Sector
- Health Care
Identifier
- ISIN
- CH1243598427
- Primary Ticker
- SDZ